long term side effects of glp 1 agonists Glucagon-like Receptor-1 for obesity: Weight loss outcomes, tolerability, effects, and risks GLP-1 Drugs and the Physiology

In overweight cats, dietary L-carnitine supplementation has been studied for its potential to support fat metabolism and body condition (Center SA, 2012)

Barriers to initiating treatment may include delayed recognition of obesity as a disease by public health and medical organizations, provider biases regarding patients with obesity, lack of reimbursement leading to out-of-pocket costs to patients, inadequate training of providers, historical safety issues with AOMs, and perceptions of patients and their caregivers regarding the efficacy of AOMs [14,15,16,17]

Light & stimulants: Limit blue-light exposure and stimulants (caffeine, nicotine) in the hours before bed

These would also help raise and engage with wider political claims around urban inclusion, socio-ecological justice, city-zenship and the right to city(life), which David Harvey (2003), Colin McFarlane (2024) and several others have convincingly argued for